Kasherman, L.; Doi, J.; Karakasis, K.; Schiff, J.; Kitchlu, A.; Lheureux, S.; Oza, A.M.
Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature. Curr. Oncol. 2021, 28, 661-670.
https://doi.org/10.3390/curroncol28010064
AMA Style
Kasherman L, Doi J, Karakasis K, Schiff J, Kitchlu A, Lheureux S, Oza AM.
Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature. Current Oncology. 2021; 28(1):661-670.
https://doi.org/10.3390/curroncol28010064
Chicago/Turabian Style
Kasherman, Lawrence, Jeffrey Doi, Katherine Karakasis, Jeffrey Schiff, Abhijat Kitchlu, Stephanie Lheureux, and Amit M. Oza.
2021. "Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature" Current Oncology 28, no. 1: 661-670.
https://doi.org/10.3390/curroncol28010064
APA Style
Kasherman, L., Doi, J., Karakasis, K., Schiff, J., Kitchlu, A., Lheureux, S., & Oza, A. M.
(2021). Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature. Current Oncology, 28(1), 661-670.
https://doi.org/10.3390/curroncol28010064